Microbiome NewsIn a study published in The Journal of nutrition, researchers investigated how dietary intake of alpha-linolenic acid (ALA) affects the composition of breast milk and the intestinal microbiota of neonates. The study focused on the use of "Bleu-Blanc-Coeur®" (BBC) food products, which are enriched with ALA, a type of n-3 polyunsaturated fatty acid (PUFA).
Study Design and Methodology
This randomized clinical trial was conducted at a single center and involved adult women who were less than 28 weeks into their pregnancies. The participants were divided into two groups: one group substituted their usual diet with BBC products rich in ALA from the seventh month of pregnancy until 45 days postpartum, while the control group continued with their regular diet. A total of 66 women were initially included, with 58 completing the study and being analyzed.
The primary aim was to assess whether the increased ALA intake would elevate ALA levels in breast milk by day 21 postpartum. Secondary aims included examining changes in the fatty acid profile, human milk oligosaccharides (HMOs), hormone levels, immune components of breast milk, and the intestinal microbiota of the neonates.
Key Findings
The results demonstrated that breast milk from the BBC group had significantly higher levels of ALA and n-3 PUFAs compared to the control group. Specifically, ALA levels were 75% higher at day 21 postpartum and 38% higher at day 45 postpartum in the BBC group. Similarly, n-3 PUFA levels were 52% higher at day 21 postpartum and 22% higher at day 45 postpartum.
In addition to these nutritional changes, the study found differences in the lipidome, insulin, interleukin-6 (IL-6), immunoglobulin G (IgG), and HMO levels in breast milk at day 21 postpartum. Notably, the alpha-diversity of the fecal microbiota in neonates was greater in the BBC group than in the control group, suggesting that maternal diet can influence the early microbial environment of infants.
Implications and Limitations
The study highlights the potential for dietary modifications during pregnancy and lactation to alter the composition of breast milk and, consequently, the microbiota of neonates. While these findings are promising, they are preliminary and require further investigation to determine any long-term health implications for infants.
One limitation of the study is its relatively small sample size, with only 58 women completing the trial. Additionally, the study was conducted in a single center, which may limit the generalizability of the results. Further research with larger, more diverse populations is needed to confirm these findings and explore their potential health impacts.
For more on how diet can influence the microbiome, you might be interested in our article on gut microbiota-accessible foods.
Frequently asked
What is alpha-linolenic acid?
Alpha-linolenic acid (ALA) is a type of n-3 polyunsaturated fatty acid (PUFA) found in various plant oils. It is an essential fatty acid, meaning it must be obtained through the diet as the body cannot produce it on its own.
How does ALA affect breast milk?
The study found that increased intake of ALA through enriched food products led to higher levels of ALA and other n-3 PUFAs in breast milk. This change in composition could potentially influence the nutritional and non-nutritional properties of the milk.
What are the implications of changes in neonatal microbiota?
Changes in the diversity of the neonatal microbiota, as observed in the study, could have implications for infant health and development. However, further research is needed to understand the long-term effects of these changes.